{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih6n65wzg7riwp43dpdqbya4fp2cdinlu2var4qkaz5o6qmpo7dni",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mi25tzcrzvb2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigggivw4mepfajvbvda5a6xxelcb7ttk3xvuqfdzj76whzbs2b3nq"
    },
    "mimeType": "image/jpeg",
    "size": 437487
  },
  "path": "/news/2026-03-triple-pre-surgery-therapy-boost.html",
  "publishedAt": "2026-03-27T07:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Early results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and Stanford Medicine suggest that combining targeted radiation therapy with an experimental immune-boosting drug called BO-112 and anti-PD-1 therapy before surgery may help the immune system fight aggressive soft tissue sarcomas.",
  "title": "Triple pre-surgery therapy may boost immunity against soft tissue sarcoma"
}